Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1957 ARTÍCULOS , VIENDO DEL 1816 AL 1830

Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension

Nakamura Y, Kurokawa T, Terashima S, Nishimura A.

J Alzheimers Dis. 2026 Jan;109(2):1007-1019. doi: 10.1177/13872877251401601. Epub 2025 Dec 9.

Efficacy and Safety of Gantenerumab in Patients With Alzheimer Disease: A Systematic Review and Meta-analysis

Alla D, Malireddi A, Ramsundar R, Shah D, Alla SSM, Das A, Andanappa A, Emmanuel NW, Siddiqui S, Marepalli NR, Dugyala RR, Kolte R.

Clin Neuropharmacol. 2026 Jan-Feb 01;49(1):4-10. doi: 10.1097/WNF.0000000000000661. Epub 2025 Nov 24.

Equine-Assisted Intervention and Alzheimer's Disease: A Non-randomized, Controlled, Multicenter Study

Badin L, Bailly N.

J Appl Gerontol. 2026 Apr;45(4):655-664. doi: 10.1177/07334648251351697. Epub 2025 Jun 18.

First unified time-course of Alzheimer's-like pathology in the intracerebroventricular streptozotocin-rat model: A systematic review

León-Arcia K, Andrade-Guerrero J, Martínez-Orozco H, Villegas-Rojas MM, Pérez-Segura I, Ramírez IL, Vilches-Flores A, Guerra-Crespo M, Díaz-Miranda SY, Soto-Rojas LO.

Ageing Res Rev. 2026 Jan;113:102918. doi: 10.1016/j.arr.2025.102918. Epub 2025 Oct 13.

Cerebrospinal fluid catecholamines levels in Alzheimer's disease, frontotemporal dementia, and normal controls

Portela Moreira I, Serrão P, Sequeira L, Sá MJ, Guimarães J, Vieira-Coelho MA.

Neurodegener Dis Manag. 2026 Apr-Jun;16(3):253-261. doi: 10.1080/17582024.2025.2554527. Epub 2025 Aug 29.

Safety and efficacy of transcranial ultrasound stimulation for the treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Fuh JL, Wang SJ, Wang PN, Wu HM, Su WS, Lin HM, Yang FY.

Ultrasonics. 2026 Mar;159:107844. doi: 10.1016/j.ultras.2025.107844. Epub 2025 Oct 3.

Initial Real-World Evidence for Lecanemab in the United States

Brixner DI, Zhao C, Toyosaki H, Frech FH, Rosenbloom MH.

Drugs Aging. 2026 Jan;43(1):69-76. doi: 10.1007/s40266-025-01261-x. Epub 2025 Oct 29.

The effects of Lithium on Beta-amyloid deposition and tau phosphorylation: A systematic review

Xiao K, Sayed H, Xing J, Zhang XY, Ai J, Kirichek E, Le GH, Wong S, Valentino K, Teopiz KM, Vinberg M, Rosenblat JD, Lo HKY, Zhang MC, McIntyre RS.

J Affect Disord. 2026 Feb 15;395(Pt A):120721. doi: 10.1016/j.jad.2025.120721. Epub 2025 Nov 17.

Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial

Edison P, Femminella GD, Ritchie C, Nowell J, Holmes C, Walker Z, Ridha B, Raza S, Livingston NR, Frangou E, Love S, Williams G, Lawrence R, Mcfarlane B, Archer H, Coulthard E, Underwood BR, Koranteng P, Karim S, Bannister C, Perneczky R, Prasanna A, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Holscher C, Mansouri A, Chester-Jones M, Holmes J, Tan T, Williams S, Ashraf A, Brooks DJ, Harrison J, Hinz R, Tadros G, Passmore AP, Ballard C.

Nat Med. 2026 Jan;32(1):353-361. doi: 10.1038/s41591-025-04106-7. Epub 2025 Dec 1.

Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension

Zimmer JA, Sims JR, Evans CD, Nery ESM, Wang H, Wessels AM, Tronchin G, Sato S, Raket LL, Andersen SW, Sapin C, Paget MA, Gueorguieva I, Ardayfio P, Khanna R, Brooks DA, Matthews BR, Mintun MA; Alzheimer’s Disease Neuroimaging Initiative.

J Prev Alzheimers Dis. 2026 Feb;13(2):100446. doi: 10.1016/j.tjpad.2025.100446. Epub 2025 Dec 1.

Subclinical Epileptiform Discharge in Patients With Alzheimer Dementia: A Systematic Review and Meta-Analysis

Yeh WC, Yang YH, Li YS, Hsu CY.

J Clin Neurophysiol. 2026 Feb 1;43(2):121-128. doi: 10.1097/WNP.0000000000001148. Epub 2025 Feb 18.

Inflammation as a mediator of air pollution's role in Alzheimer's disease and related dementias

Zhao B, Geng C, Zhou S, Wei T, Li A, Zhao Y, Tang Y.

J Alzheimers Dis. 2026 Feb;109(4):1649-1662. doi: 10.1177/13872877251408422. Epub 2025 Dec 29.

Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences

Balakrishnan R, Subbarayan R, Shrestha R, Chauhan A.

Biochem Genet. 2026 Jun;64(3):3140-3165. doi: 10.1007/s10528-025-11208-x. Epub 2025 Jul 28.

Unveiling Alzheimer's disease (1901-2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies

Baviskar PS, Mahajan HS.

Ageing Res Rev. 2026 Jan;114:102990. doi: 10.1016/j.arr.2025.102990. Epub 2025 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias